Phase 4 N=14 Varenicline Effects In Schizophrenic Smokers
Schizophrenia · Tobacco Use Disorder · Nicotine Dependance
Primary: Self Report of Smoking — 36.45; 17.25; 12.52 Cigarettes
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=20 Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients
Type-2 Diabetes Mellitus · Coronary Artery Disease
Primary: Thrombus Formation — 66.9; 84.4; 59.9; 79.8 percentage of baseline size
Phase 4 N=21 Protective Effects of Propylene Glycol in Daily Acetaminophen Dosing
Acetaminophen Toxicity
Primary: Rise in Plasma Transaminases: Proportion of Responders. — 6; 8 Participants — p=0.59
Phase 4 N=6 Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication
Pulmonary Arterial Hypertension
Primary: Number of Participants Without Adverse Events — 6 Participants
Phase 4 N=165 Peripheral Nerve Blocks vs Periarticular Local Anesthetic Injection for Total Knee Arthroplasty (TKA)
Total Knee Arthroplasty
Primary: Maximum Pain Post-Operative Day (POD) 1 (Morning) — 3; 4; 4.5 units on a scale — p=0.144
Phase 4 N=15 Effect of Ethanol Intoxication on the Anti-Hypoglycemic Action of Glucagon
Type 1 Diabetes Mellitus
Primary: AOCGIR (Area Over the Curve for Glucose Infusion Rate) — 1996; 1981 mg*minute/dl
Phase 4 N=31 Comparison Between Methadone and Morphine for Neonatal Opiate Withdrawal
Neonatal Abstinence Syndrome
Primary: Days of Treatment With Opioid Medication — 13.9; 22.9 days
Phase 4 N=68 Does the Addition of Epinephrine Prolong the Duration of Spinal Anesthesia for Repeat Cesarean Section?
Spinal Anesthesia · Cesarean Section
Primary: Sensory Recovery — 135; 165; 120 minutes
Phase 4 N=106 Does Duloxetine Reduce Sub-Acute Pain After Knee Arthroplasty?
Total Knee Arthroplasty
Primary: NRS Pain With Ambulation at 2 Weeks — 3.5; 3.8 NRS pain score
Phase 4 N=43 Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB
Chronic Hepatitis B
Primary: Proportion of Participants With HBsAg Loss at Week 144 in Both Study Arms — 0.236; 0 Proportion of participants — p=0.022
Phase 4 N=75 Efficacy Study of Quetiapine Plus Topiramate for Reducing Cannabis Consumption and Bipolar Mania
Bipolar Disorder · Cannabis-Related Disorder
Primary: Change in Joints Per Week — -10.1; -10.7 joints
Phase 4 N=86 Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease
Moderate to Severe Crohn's Disease
Primary: Percentage of Participants With Clinical Response at Day 4 — 61.63 percentage of participants
Phase 4 N=26 Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD
Chronic Obstructive Pulmonary Disease
Primary: Change From Baseline of Systemic Markers of Bone Metabolism (C-terminal Peptide of Type 1 Collagen (CTx) and Amino-terminal Propeptide of Type-1 Procollagen (P1NP))…
Phase 4 N=75 Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder
Borderline Personality Disorder
Primary: Suicide Attempts — 2; 1; 4; 1 suicide attempt
Phase 4 N=20 Comparison of Wound Bed Establishment in Facial Burns
Burns
Primary: Time to Wound Epithelialization — 37.4; 37.6 days — p=.0853